I don't think much of the IDO1 inhibitor in comparison to Cavatak. However I will look at those results more thoroughly.
Cavatak is (now) a targeting mechanism, while the checkpoint-inhibitor super charges the immune response (inhibits the automatic down-regulators abused by tumours under attack).
IDO1 inhibitor plus another checkpoint-inhibitor is less exciting to me.
- Forums
- ASX - By Stock
- VLA
- Think before you act
Think before you act, page-26
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm